PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24555753-6	2014	Significant differences in nasal cytokine levels (interleukin-5 and -8) were also observed between the low-dose and high-dose groups after short-term clarithromycin treatment (p < 0.025).	Clarithromycin	150-164	interleukin 5	Homo sapiens	50-70	
9597458-0	1997	[Effects and actions of EM (erythromycin), CAM (clarithromycin), and JM (josamycin) on IL-4 and IL-5 production by monocytes].	Clarithromycin	48-62	interleukin 5	Homo sapiens	96-100	
8977529-6	1996	RESULTS: Aminophylline (AM), methylprednisolone (MP), erythromycin (EM), and clarithromycin (CAM) suppressed the IL-5 induced prolongation of eosinophil survival in a dose-dependent manner.	Clarithromycin	77-91	interleukin 5	Homo sapiens	113-117	
8977529-6	1996	RESULTS: Aminophylline (AM), methylprednisolone (MP), erythromycin (EM), and clarithromycin (CAM) suppressed the IL-5 induced prolongation of eosinophil survival in a dose-dependent manner.	Clarithromycin	93-96	interleukin 5	Homo sapiens	113-117	
12368623-7	2002	RESULTS: Clarithromycin and prednisolone each produced significant reductions in interleukin-5, interleukin-8, and granulocyte-macrophage colony-stimulating factor production.	Clarithromycin	9-23	interleukin 5	Homo sapiens	81-94	
12065339-12	2002	However, the PCR-positive subjects who received clarithromycin demonstrated a reduction in TNF-alpha (p = 0.006), IL-5 (p = 0.007), and IL-12 (p = 0.004) mRNA in BAL and TNF-alpha mRNA in airway tissue (p = 0.0009).	Clarithromycin	48-62	interleukin 5	Homo sapiens	114-118